Approved for Nosocomial pneumonia caused by MRSA or Streptococcus pneumoniae, Vancomycin-resistant Enterococcus faecium infections, Complicated skin infections. Inhibits bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S subunit, preventing formation of the initiation complex. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA…
Loading full data from Know Your Drugs Institute…